# The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

> **NCT02297620** · — · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 8687 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Suglat®

## Key facts

- **NCT ID:** NCT02297620
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 8687 (ACTUAL)
- **Last updated:** 2015-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02297620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02297620, "The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02297620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*